- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
SBC Medical Group Holdings Incorporated(SBC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SBC
11/20/2026: SBC (1-star) is a SELL. SELL for 1 day. Simulated Profits (41.26%). Updated daily EoD!
SBC Medical Group Holdings Incorporated operates as a prominent medical services organization providing management and operational support to cosmetic and healthcare clinics primarily in Japan and abroad. The company exhibits robust operating margins, strong cash flow generation, and consistent network expansion across multiple aesthetic brands. Its primary growth strategy involves scaling international operations and diversifying into high-potential non-aesthetic fields like longevity medicine. Key risks include heavy reliance on discretionary consumer spending, localized geographic exposure, and intense competition within elective healthcare. Suited for growth-oriented investors, the stock warrants close monitoring of international execution, AI-driven efficiencies, and regulatory developments.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company delivers rapid top-line and earnings expansion driven by network scaling and international MSO opportunities. |
| Momentum investor | Strong fit while signal remains positive | Favorable earnings reports and solid quarterly momentum can attract technical interest conditional on positive market sentiment. |
| Value investor | Mixed fit | While operating profitability is high, valuation multiples fluctuate based on sentiment toward small-cap cross-border listings. |
| Dividend investor | Weak fit | The company prioritizes capital reinvestment and business expansion over regular dividend payouts. |
| Low-risk investor | Weak fit | Small-cap cross-border listing characteristics and exposure to discretionary consumer trends introduce notable volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Smaller public float and micro-to-small cap status can lead to sharp short-term price fluctuations. |
| Valuation risk | Medium | Valuations depend heavily on sustained high growth rates matching investor expectations. |
| Competition risk (aesthetic and medical MSO competition) | Medium / high | Intense market competition requires continuous innovation and service differentiation to protect margins. |
| Business quality | Strong | The franchise MSO model generates high operating and EBITDA margins with solid cash conversion. |
| Dividend income | Low / none | No regular dividend yield is offered as capital is retained for expansion. |
| Execution risk | Medium | Successful international expansion and entry into new medical verticals require flawless operational execution. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 530.32M USD | Price to earnings Ratio 10.14 | 1Y Target Price 10 |
Price to earnings Ratio 10.14 | 1Y Target Price 10 | ||
Volume (30-day avg) 312.6K shares | Beta 0.52 | 52 Weeks Range 2.78 - 7.39 | Updated Date 11/21/2026 |
52 Weeks Range 2.78 - 7.39 | Updated Date 11/21/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.51 |
Sector & Industry Intelligence
Sector
Industrials
Watchful- Sentiment
- Weak Bearish
- Momentum
- BUY Breadth Improving
- BUY participation
- 25.6%
- Active BUY / eligible
- 20 / 78
- 30-Day BUY Count Change
- +6
- Market state
- Weak Bearish / Bullish Reversal
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Consulting Services
- BUY participation
- 0.0%
- Active BUY / eligible
- 0 / 1
- 30-Day BUY Count Change
- -1
Eligible universe: 1 stock.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 5.07% | Avg. Invested days 47 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| MSO Management & Franchise Services | Fees charged to partner medical institutions for administrative support, IT systems, and trademark licensing. | SBC acts as the backbone service provider for clinics, earning predictable management fees based on network performance. |
| Marketing & Advertising Solutions | Digital marketing campaigns and customer acquisition services tailored for aesthetic clinics. | Helps clinics attract patients efficiently while capturing marketing-related revenue streams. |
| Medical Equipment & Consumables Supply | Wholesale procurement and supply of specialized medical goods to partner clinics. | Generates steady commercial revenue from essential supplies utilized daily across the clinic network. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-13 | When Before Market | Estimate 0.11 | Actual 0.15 |
Profitability
Profit Margin 27.26% | Operating Margin (TTM) 39.89% |
Management Effectiveness
Return on Assets (TTM) 12.72% | Return on Equity (TTM) 19.29% |
Valuation
Trailing PE 10.14 | Forward PE 12.02 | Enterprise Value 484.46M | Price to Sales(TTM) 2.79 |
Enterprise Value 484.46M | Price to Sales(TTM) 2.79 | ||
Enterprise Value to Revenue 2.53 | Enterprise Value to EBITDA 5.52 | Shares Outstanding 102.58M | Shares Floating 18.10M |
Shares Outstanding 102.58M | Shares Floating 18.10M | ||
Percent Insiders 81.53 | Percent Institutions 5.41 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

